PhD student (m/f/d) in the interna­tional doctorate program “i-Target” sponsored by the Elite Network Bavaria

PhD student (m/f/d) in the interna­tional doctorate program “i-Target” sponsored by the Elite Network Bavaria

Ludwig-Maximilians-Universität (LMU) in Munich

Munich, Germany

The Hospital of the University of Munich, Germany, is one of the largest and most competitive university hospitals in Germany and Europe. 47 specialized hospitals, departments and institutions harbouring excellent research and education provide patient care at the highest medical level with approximately 10.000 employees.

The Division of Clinical Pharmacology, Medizinische Klinik und Poliklinik IV, invites applications as

PhD student (m/f/d) in the interna­tional doctorate program “i-Target” sponsored by the Elite Network Bavaria

Scope of the program:

Tumor immunotherapy is subject of intense scientific and clinical development. The requirements of well-trained scientists in this research field is rapidly increasing, both in industry and academy. There are currently no structured training programs in Germany to train prospective scientists specifically in the field of immunotherapies. To fill this gap, a team of ten Bavarian professors under the lead of the Ludwig-Maximilians-Universität München (speaker: Prof. Endres, scientific coordinator: Dr. Kobold) have joined forces to investigate innovative immunotherapies and to train talented PhD students in this highly competitive research field. The high scientific level of the investigators will guarantee projects at the cutting edge of research (Anger et al. Nature 2013; Civril et al. Nature 2013; Kobold et al. JNCI 2015; Wartewig et al. Nature 2017; Voigt et al., PNAS 2017). Three fields of immunotherapy will be investigated: Targeted cell-based therapies, targeted antibody therapy and immunomodulatory therapy (that counteracts tumor-derived immunosuppression).

We seek:

We expect applications from graduate students in medicine, biology, immunology or pharmacy with an excellent academic background. Applications can come from Germany and from abroad. Applicants are required to have graduated above average at a Master level or equivalent by the time of their application. He or she should have a background in cell biology or immunology with experimental experience in protein biochemistry and/or molecular biology and the willingness to also work with mice. The applicant should be fluent in English.

We offer:

Starting as soon as possible, we offer a position for a PhD student in the international doctorate program “i-Target” under the supervision of PI Dr. Sebastian Kobold. A description of the research project can be found on Besides the experimental work towards the PhD degree the doctorate program involves a structured training program with weekly seminars, lectures given by internationally recognized speakers, hands-on methods courses, annual research retreats as well as soft skill seminars. Scholarships of the doctorate program are awarded for one year with the possibility of extension for three further years.

The University welcomes and encourages interest from handicapped candidates. Presentation and traveling costs can unfortunately not be refunded.

For more information please contact:

Application deadline is December 1st 2018.

Please note that in case of transmitting your job application by email your data will not be encrypted and might potentially be noticed or adulterated by unauthorized third parties.

Please send your application using the reference number 2018-K-0449 to:

Klinikum der Universität München
Abteilung für Klinische Pharmakologie
Lindwurmstraße 2a
80337 Munich


Apply with CV and Cover Letter

Fields with a * are mandatory
Must be a .doc, .docx, or .pdf file and no larger than 1MBMust be a .doc, .docx, or .pdf file and no larger than 1MB

PhD student (m/f/d) in the interna­tional doctorate program “i-Target” sponsored by the Elite Network Bavaria